| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma
|
Portuguese, Andrew J.
|
|
|
7 |
23 |
p. 7235-7238
|
article
|
| 2 |
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease
|
Hankins, Jane S.
|
|
|
7 |
23 |
p. 7190-7201
|
article
|
| 3 |
Another step toward frontline BTK inhibitor therapy in MCL
|
Hanel, Walter
|
|
|
7 |
23 |
p. 7358-7360
|
article
|
| 4 |
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
|
Teierle, Samantha M.
|
|
|
7 |
23 |
p. 7239-7242
|
article
|
| 5 |
COVID-19 in patients with classic and variant hairy cell leukemia
|
Kreitman, Robert J.
|
|
|
7 |
23 |
p. 7161-7168
|
article
|
| 6 |
Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL
|
O’Connor, David
|
|
|
7 |
23 |
p. 7231-7234
|
article
|
| 7 |
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
|
Spasevska, Ivana
|
|
|
7 |
23 |
p. 7216-7230
|
article
|
| 8 |
Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis
|
Verkamp, Bethany
|
|
|
7 |
23 |
p. 7258-7269
|
article
|
| 9 |
E-cadherin/β-catenin expression is conserved in human and rat erythropoiesis and marks stress erythropoiesis
|
Krimpenfort, Rosa A.
|
|
|
7 |
23 |
p. 7169-7183
|
article
|
| 10 |
Editorial Board
|
|
|
|
7 |
23 |
p. i
|
article
|
| 11 |
Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome
|
Jiang, Debbie
|
|
|
7 |
23 |
p. 7202-7208
|
article
|
| 12 |
Front Matter
|
|
|
|
7 |
23 |
p. ii
|
article
|
| 13 |
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
|
Camus, Vincent
|
|
|
7 |
23 |
p. 7331-7345
|
article
|
| 14 |
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type
|
Emile, Jean-François
|
|
|
7 |
23 |
p. 7254-7257
|
article
|
| 15 |
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma
|
Karmali, Reem
|
|
|
7 |
23 |
p. 7361-7368
|
article
|
| 16 |
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
|
Syrykh, Charlotte
|
|
|
7 |
23 |
p. 7384-7391
|
article
|
| 17 |
JAK2V617F and ischemic stroke: CHIP or CMD-NBV?
|
Barosi, Giovanni
|
|
|
7 |
23 |
p. 7329-7330
|
article
|
| 18 |
Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioning
|
Nolan, Erin E.
|
|
|
7 |
23 |
p. 7290-7294
|
article
|
| 19 |
Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice
|
Lee, Grace
|
|
|
7 |
23 |
p. 7185-7189
|
article
|
| 20 |
Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A
|
Agosti, Pasquale
|
|
|
7 |
23 |
p. 7209-7215
|
article
|
| 21 |
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
|
Durham, Benjamin H.
|
|
|
7 |
23 |
p. 7319-7328
|
article
|
| 22 |
Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma
|
Phillips, Nicholas S.
|
|
|
7 |
23 |
p. 7270-7278
|
article
|
| 23 |
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
|
Desai, Sanjal H.
|
|
|
7 |
23 |
p. 7295-7303
|
article
|
| 24 |
Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant
|
Lin, Andrew
|
|
|
7 |
23 |
p. 7153-7160
|
article
|
| 25 |
Pirillo C, Birch F, Tissot FS, et al. Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness. Blood Adv. 2022;6(10):3126-3141.
|
|
|
|
7 |
23 |
p. 7184
|
article
|
| 26 |
Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell disease
|
Gonzalez Sepulveda, Juan Marcos
|
|
|
7 |
23 |
p. 7371-7381
|
article
|
| 27 |
Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice
|
Ahmad, Mohd Hafiz
|
|
|
7 |
23 |
p. 7304-7318
|
article
|
| 28 |
The challenge of eliciting opinions of gene therapy for SCD
|
Limerick, Emily M.
|
|
|
7 |
23 |
p. 7369-7370
|
article
|
| 29 |
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing
|
Maierhofer, Anna
|
|
|
7 |
23 |
p. 7346-7357
|
article
|
| 30 |
The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
|
Hijiya, Nobuko
|
|
|
7 |
23 |
p. 7279-7289
|
article
|
| 31 |
Time to include IGLV3-21R110 status in CLL prognostication?
|
Rosenquist, Richard
|
|
|
7 |
23 |
p. 7382-7383
|
article
|
| 32 |
TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era
|
Landsburg, Daniel J.
|
|
|
7 |
23 |
p. 7243-7253
|
article
|
Journal description